Inhibition of Protein-Kinase C in Peripheral Blood Mononuclear Cells of Patients with Systemic Lupus Erythematosus: Effect on Spontaneous Immunoglobulin Production

Systemic Lupus Erythematosus (SLE) is a multisystem disease characterized by an increase in the spontaneous secretion of immunoglobulin (Ig) molecules, many of which are autoreactive. We have previously shown (Biochem & Biophys. Res. Comm. (1989) 161: 1319-1326) that normal human peripheral bloo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Autoimmunity (Chur, Switzerland) Switzerland), 1991, Vol.10 (3), p.227-231
Hauptverfasser: Chong, Penny, Matzner, William I., Yamiguchi, Dean, Wallace, Daniel, Klinenberg, James R., Jordan, Stanley C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 231
container_issue 3
container_start_page 227
container_title Autoimmunity (Chur, Switzerland)
container_volume 10
creator Chong, Penny
Matzner, William I.
Yamiguchi, Dean
Wallace, Daniel
Klinenberg, James R.
Jordan, Stanley C.
description Systemic Lupus Erythematosus (SLE) is a multisystem disease characterized by an increase in the spontaneous secretion of immunoglobulin (Ig) molecules, many of which are autoreactive. We have previously shown (Biochem & Biophys. Res. Comm. (1989) 161: 1319-1326) that normal human peripheral blood mononuclear cells (PBMCs) can be stimulated to secrete large quantities of Ig upon incubation with the protein kinase-C activator 1 oleoyl-2-acetylglycerol (OAG). Specific blockage of protein kinase C with the isoquinoline sulfonyl piperazine compound (H-7) inhibited the OAG-induced Ig production. In experiments reported here, PBMC of 5 patients with active SLE produced high levels of IgG spontaneoulsy in culture. PBMC of 6 inactive SLE patients and 7 normal control subjects produced comparable low levels of IgG spontaneously. Pokeweed mitogen (PWM) stimulation of PBMC in inactive SLE and control groups, but not active SLE patients produced markedly enhanced IgG production. The lack of response to PWM stimulation in active SLE patients is likely due to inherent maximal stimulation of active SLE B-cells. In addition, we examined the ability of H-7 to inhibit both mitogen-stimulated (normal and inactive SLE) and spontaneous (active SLE) Ig production. In other experiments, we also examined the ability of the isoquinoline sulfonamide (HA-1004), a potent inhibitor of cAMP-dependent protein kinase to regulate mitogen stimulated and spontaneous Ig production in the patient groups indicated above. H-7 significantly inhibited PWM stimulated Ig production in normal (P < 0.0001) and inactive SLE patients, (P < 0.040) suppressing PWM stimulated levels to spontaneous levels. HA-1004 inhibition of cAMP-dependent protein kinase had no inhibitory effect on Ig production in inactive and active SLE patients. These findings suggest that protein kinase C activation is critical to PWM-stimulated IgG production in normal and inactive SLE patients, and is also important in the high spontaneous IgG production found in active SLE patients. Although H-7 was also a potent inhibitor of spontaneous IgG production in active SLE patients, this did not reach statistical significance.
doi_str_mv 10.3109/08916939109001893
format Article
fullrecord <record><control><sourceid>proquest_pasca</sourceid><recordid>TN_cdi_pascalfrancis_primary_5024381</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72579543</sourcerecordid><originalsourceid>FETCH-LOGICAL-c430t-c4ce5153bd6f309d3768f2013739ac39fc549f23700a29cd0844b279c17c38253</originalsourceid><addsrcrecordid>eNp9kc2KFDEUhYMoYzv6AC6ELMRdaX6qKhWdjTatNrY4MAruinQqsTKkkjI_DP08vqhpq1VEmE0SON-599xcAB5j9JxixF-gjuOWU17eCOGO0ztghVvEqq4mX--C1VGvClDfBw9ivEYIEdbWZ-AMs6YlpFmBH1s3mr1JxjvoNbwMPinjqg_GiajgGhoHL1Uw86iCsPCN9X6AH73zLkurRIBrZW385RTJKJcivDFphFeHmNRkJNzlOUe4CYc0qkkkH3N8CTdaK5lgaXk1e5eEU75A22nKzn-zfp_tsW3wQ5bHYA_BPS1sVI9O9zn48nbzef2-2n16t12_3lWypiiVU6oGN3Q_tJoiPlDWdpogTBnlQlKuZVNzTShDSBAuB9TV9Z4wLjGTtCMNPQfPlrpz8N-ziqmfTJRlwCVgz0jDeFPTAuIFlMHHGJTu52AmEQ49Rv1xMf1_iymeJ6fieT-p4a9j2UTRn550EaWwOggnTfyDNYjUtMMFu1gw47QPk7jxwQ59Egfrw28PvS3Fq3_soxI2jVIE1V_7HFz53ltm-AkNGb1G</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72579543</pqid></control><display><type>article</type><title>Inhibition of Protein-Kinase C in Peripheral Blood Mononuclear Cells of Patients with Systemic Lupus Erythematosus: Effect on Spontaneous Immunoglobulin Production</title><source>MEDLINE</source><source>Taylor &amp; Francis Journals Complete</source><creator>Chong, Penny ; Matzner, William I. ; Yamiguchi, Dean ; Wallace, Daniel ; Klinenberg, James R. ; Jordan, Stanley C.</creator><creatorcontrib>Chong, Penny ; Matzner, William I. ; Yamiguchi, Dean ; Wallace, Daniel ; Klinenberg, James R. ; Jordan, Stanley C.</creatorcontrib><description>Systemic Lupus Erythematosus (SLE) is a multisystem disease characterized by an increase in the spontaneous secretion of immunoglobulin (Ig) molecules, many of which are autoreactive. We have previously shown (Biochem &amp; Biophys. Res. Comm. (1989) 161: 1319-1326) that normal human peripheral blood mononuclear cells (PBMCs) can be stimulated to secrete large quantities of Ig upon incubation with the protein kinase-C activator 1 oleoyl-2-acetylglycerol (OAG). Specific blockage of protein kinase C with the isoquinoline sulfonyl piperazine compound (H-7) inhibited the OAG-induced Ig production. In experiments reported here, PBMC of 5 patients with active SLE produced high levels of IgG spontaneoulsy in culture. PBMC of 6 inactive SLE patients and 7 normal control subjects produced comparable low levels of IgG spontaneously. Pokeweed mitogen (PWM) stimulation of PBMC in inactive SLE and control groups, but not active SLE patients produced markedly enhanced IgG production. The lack of response to PWM stimulation in active SLE patients is likely due to inherent maximal stimulation of active SLE B-cells. In addition, we examined the ability of H-7 to inhibit both mitogen-stimulated (normal and inactive SLE) and spontaneous (active SLE) Ig production. In other experiments, we also examined the ability of the isoquinoline sulfonamide (HA-1004), a potent inhibitor of cAMP-dependent protein kinase to regulate mitogen stimulated and spontaneous Ig production in the patient groups indicated above. H-7 significantly inhibited PWM stimulated Ig production in normal (P &lt; 0.0001) and inactive SLE patients, (P &lt; 0.040) suppressing PWM stimulated levels to spontaneous levels. HA-1004 inhibition of cAMP-dependent protein kinase had no inhibitory effect on Ig production in inactive and active SLE patients. These findings suggest that protein kinase C activation is critical to PWM-stimulated IgG production in normal and inactive SLE patients, and is also important in the high spontaneous IgG production found in active SLE patients. Although H-7 was also a potent inhibitor of spontaneous IgG production in active SLE patients, this did not reach statistical significance.</description><identifier>ISSN: 0891-6934</identifier><identifier>EISSN: 1607-842X</identifier><identifier>DOI: 10.3109/08916939109001893</identifier><identifier>PMID: 1756225</identifier><language>eng</language><publisher>Abingdon: Informa UK Ltd</publisher><subject>1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine ; Adult ; Autoantibodies - analysis ; Biological and medical sciences ; Cells, Cultured - drug effects ; Female ; Humans ; Immunoglobulin G - analysis ; Immunoglobulin G - blood ; immunoglobulin production ; Isoquinolines - pharmacology ; Lupus Erythematosus, Systemic - blood ; Male ; Medical sciences ; Monocytes - drug effects ; Monocytes - enzymology ; Monocytes - immunology ; Piperazines - pharmacology ; Pokeweed Mitogens ; Protein Kinase C - antagonists &amp; inhibitors ; Protein Kinase C - blood ; protein-kinase C ; Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis ; SLE ; Sulfonamides</subject><ispartof>Autoimmunity (Chur, Switzerland), 1991, Vol.10 (3), p.227-231</ispartof><rights>1991 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 1991</rights><rights>1992 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c430t-c4ce5153bd6f309d3768f2013739ac39fc549f23700a29cd0844b279c17c38253</citedby><cites>FETCH-LOGICAL-c430t-c4ce5153bd6f309d3768f2013739ac39fc549f23700a29cd0844b279c17c38253</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.tandfonline.com/doi/pdf/10.3109/08916939109001893$$EPDF$$P50$$Ginformaworld$$H</linktopdf><linktohtml>$$Uhttps://www.tandfonline.com/doi/full/10.3109/08916939109001893$$EHTML$$P50$$Ginformaworld$$H</linktohtml><link.rule.ids>314,776,780,4010,27900,27901,27902,59620,60409,61194,61375</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=5024381$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1756225$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chong, Penny</creatorcontrib><creatorcontrib>Matzner, William I.</creatorcontrib><creatorcontrib>Yamiguchi, Dean</creatorcontrib><creatorcontrib>Wallace, Daniel</creatorcontrib><creatorcontrib>Klinenberg, James R.</creatorcontrib><creatorcontrib>Jordan, Stanley C.</creatorcontrib><title>Inhibition of Protein-Kinase C in Peripheral Blood Mononuclear Cells of Patients with Systemic Lupus Erythematosus: Effect on Spontaneous Immunoglobulin Production</title><title>Autoimmunity (Chur, Switzerland)</title><addtitle>Autoimmunity</addtitle><description>Systemic Lupus Erythematosus (SLE) is a multisystem disease characterized by an increase in the spontaneous secretion of immunoglobulin (Ig) molecules, many of which are autoreactive. We have previously shown (Biochem &amp; Biophys. Res. Comm. (1989) 161: 1319-1326) that normal human peripheral blood mononuclear cells (PBMCs) can be stimulated to secrete large quantities of Ig upon incubation with the protein kinase-C activator 1 oleoyl-2-acetylglycerol (OAG). Specific blockage of protein kinase C with the isoquinoline sulfonyl piperazine compound (H-7) inhibited the OAG-induced Ig production. In experiments reported here, PBMC of 5 patients with active SLE produced high levels of IgG spontaneoulsy in culture. PBMC of 6 inactive SLE patients and 7 normal control subjects produced comparable low levels of IgG spontaneously. Pokeweed mitogen (PWM) stimulation of PBMC in inactive SLE and control groups, but not active SLE patients produced markedly enhanced IgG production. The lack of response to PWM stimulation in active SLE patients is likely due to inherent maximal stimulation of active SLE B-cells. In addition, we examined the ability of H-7 to inhibit both mitogen-stimulated (normal and inactive SLE) and spontaneous (active SLE) Ig production. In other experiments, we also examined the ability of the isoquinoline sulfonamide (HA-1004), a potent inhibitor of cAMP-dependent protein kinase to regulate mitogen stimulated and spontaneous Ig production in the patient groups indicated above. H-7 significantly inhibited PWM stimulated Ig production in normal (P &lt; 0.0001) and inactive SLE patients, (P &lt; 0.040) suppressing PWM stimulated levels to spontaneous levels. HA-1004 inhibition of cAMP-dependent protein kinase had no inhibitory effect on Ig production in inactive and active SLE patients. These findings suggest that protein kinase C activation is critical to PWM-stimulated IgG production in normal and inactive SLE patients, and is also important in the high spontaneous IgG production found in active SLE patients. Although H-7 was also a potent inhibitor of spontaneous IgG production in active SLE patients, this did not reach statistical significance.</description><subject>1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine</subject><subject>Adult</subject><subject>Autoantibodies - analysis</subject><subject>Biological and medical sciences</subject><subject>Cells, Cultured - drug effects</subject><subject>Female</subject><subject>Humans</subject><subject>Immunoglobulin G - analysis</subject><subject>Immunoglobulin G - blood</subject><subject>immunoglobulin production</subject><subject>Isoquinolines - pharmacology</subject><subject>Lupus Erythematosus, Systemic - blood</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Monocytes - drug effects</subject><subject>Monocytes - enzymology</subject><subject>Monocytes - immunology</subject><subject>Piperazines - pharmacology</subject><subject>Pokeweed Mitogens</subject><subject>Protein Kinase C - antagonists &amp; inhibitors</subject><subject>Protein Kinase C - blood</subject><subject>protein-kinase C</subject><subject>Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis</subject><subject>SLE</subject><subject>Sulfonamides</subject><issn>0891-6934</issn><issn>1607-842X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc2KFDEUhYMoYzv6AC6ELMRdaX6qKhWdjTatNrY4MAruinQqsTKkkjI_DP08vqhpq1VEmE0SON-599xcAB5j9JxixF-gjuOWU17eCOGO0ztghVvEqq4mX--C1VGvClDfBw9ivEYIEdbWZ-AMs6YlpFmBH1s3mr1JxjvoNbwMPinjqg_GiajgGhoHL1Uw86iCsPCN9X6AH73zLkurRIBrZW385RTJKJcivDFphFeHmNRkJNzlOUe4CYc0qkkkH3N8CTdaK5lgaXk1e5eEU75A22nKzn-zfp_tsW3wQ5bHYA_BPS1sVI9O9zn48nbzef2-2n16t12_3lWypiiVU6oGN3Q_tJoiPlDWdpogTBnlQlKuZVNzTShDSBAuB9TV9Z4wLjGTtCMNPQfPlrpz8N-ziqmfTJRlwCVgz0jDeFPTAuIFlMHHGJTu52AmEQ49Rv1xMf1_iymeJ6fieT-p4a9j2UTRn550EaWwOggnTfyDNYjUtMMFu1gw47QPk7jxwQ59Egfrw28PvS3Fq3_soxI2jVIE1V_7HFz53ltm-AkNGb1G</recordid><startdate>1991</startdate><enddate>1991</enddate><creator>Chong, Penny</creator><creator>Matzner, William I.</creator><creator>Yamiguchi, Dean</creator><creator>Wallace, Daniel</creator><creator>Klinenberg, James R.</creator><creator>Jordan, Stanley C.</creator><general>Informa UK Ltd</general><general>Taylor &amp; Francis</general><general>Taylor and Francis</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1991</creationdate><title>Inhibition of Protein-Kinase C in Peripheral Blood Mononuclear Cells of Patients with Systemic Lupus Erythematosus: Effect on Spontaneous Immunoglobulin Production</title><author>Chong, Penny ; Matzner, William I. ; Yamiguchi, Dean ; Wallace, Daniel ; Klinenberg, James R. ; Jordan, Stanley C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c430t-c4ce5153bd6f309d3768f2013739ac39fc549f23700a29cd0844b279c17c38253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine</topic><topic>Adult</topic><topic>Autoantibodies - analysis</topic><topic>Biological and medical sciences</topic><topic>Cells, Cultured - drug effects</topic><topic>Female</topic><topic>Humans</topic><topic>Immunoglobulin G - analysis</topic><topic>Immunoglobulin G - blood</topic><topic>immunoglobulin production</topic><topic>Isoquinolines - pharmacology</topic><topic>Lupus Erythematosus, Systemic - blood</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Monocytes - drug effects</topic><topic>Monocytes - enzymology</topic><topic>Monocytes - immunology</topic><topic>Piperazines - pharmacology</topic><topic>Pokeweed Mitogens</topic><topic>Protein Kinase C - antagonists &amp; inhibitors</topic><topic>Protein Kinase C - blood</topic><topic>protein-kinase C</topic><topic>Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis</topic><topic>SLE</topic><topic>Sulfonamides</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chong, Penny</creatorcontrib><creatorcontrib>Matzner, William I.</creatorcontrib><creatorcontrib>Yamiguchi, Dean</creatorcontrib><creatorcontrib>Wallace, Daniel</creatorcontrib><creatorcontrib>Klinenberg, James R.</creatorcontrib><creatorcontrib>Jordan, Stanley C.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Autoimmunity (Chur, Switzerland)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chong, Penny</au><au>Matzner, William I.</au><au>Yamiguchi, Dean</au><au>Wallace, Daniel</au><au>Klinenberg, James R.</au><au>Jordan, Stanley C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inhibition of Protein-Kinase C in Peripheral Blood Mononuclear Cells of Patients with Systemic Lupus Erythematosus: Effect on Spontaneous Immunoglobulin Production</atitle><jtitle>Autoimmunity (Chur, Switzerland)</jtitle><addtitle>Autoimmunity</addtitle><date>1991</date><risdate>1991</risdate><volume>10</volume><issue>3</issue><spage>227</spage><epage>231</epage><pages>227-231</pages><issn>0891-6934</issn><eissn>1607-842X</eissn><abstract>Systemic Lupus Erythematosus (SLE) is a multisystem disease characterized by an increase in the spontaneous secretion of immunoglobulin (Ig) molecules, many of which are autoreactive. We have previously shown (Biochem &amp; Biophys. Res. Comm. (1989) 161: 1319-1326) that normal human peripheral blood mononuclear cells (PBMCs) can be stimulated to secrete large quantities of Ig upon incubation with the protein kinase-C activator 1 oleoyl-2-acetylglycerol (OAG). Specific blockage of protein kinase C with the isoquinoline sulfonyl piperazine compound (H-7) inhibited the OAG-induced Ig production. In experiments reported here, PBMC of 5 patients with active SLE produced high levels of IgG spontaneoulsy in culture. PBMC of 6 inactive SLE patients and 7 normal control subjects produced comparable low levels of IgG spontaneously. Pokeweed mitogen (PWM) stimulation of PBMC in inactive SLE and control groups, but not active SLE patients produced markedly enhanced IgG production. The lack of response to PWM stimulation in active SLE patients is likely due to inherent maximal stimulation of active SLE B-cells. In addition, we examined the ability of H-7 to inhibit both mitogen-stimulated (normal and inactive SLE) and spontaneous (active SLE) Ig production. In other experiments, we also examined the ability of the isoquinoline sulfonamide (HA-1004), a potent inhibitor of cAMP-dependent protein kinase to regulate mitogen stimulated and spontaneous Ig production in the patient groups indicated above. H-7 significantly inhibited PWM stimulated Ig production in normal (P &lt; 0.0001) and inactive SLE patients, (P &lt; 0.040) suppressing PWM stimulated levels to spontaneous levels. HA-1004 inhibition of cAMP-dependent protein kinase had no inhibitory effect on Ig production in inactive and active SLE patients. These findings suggest that protein kinase C activation is critical to PWM-stimulated IgG production in normal and inactive SLE patients, and is also important in the high spontaneous IgG production found in active SLE patients. Although H-7 was also a potent inhibitor of spontaneous IgG production in active SLE patients, this did not reach statistical significance.</abstract><cop>Abingdon</cop><pub>Informa UK Ltd</pub><pmid>1756225</pmid><doi>10.3109/08916939109001893</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0891-6934
ispartof Autoimmunity (Chur, Switzerland), 1991, Vol.10 (3), p.227-231
issn 0891-6934
1607-842X
language eng
recordid cdi_pascalfrancis_primary_5024381
source MEDLINE; Taylor & Francis Journals Complete
subjects 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
Adult
Autoantibodies - analysis
Biological and medical sciences
Cells, Cultured - drug effects
Female
Humans
Immunoglobulin G - analysis
Immunoglobulin G - blood
immunoglobulin production
Isoquinolines - pharmacology
Lupus Erythematosus, Systemic - blood
Male
Medical sciences
Monocytes - drug effects
Monocytes - enzymology
Monocytes - immunology
Piperazines - pharmacology
Pokeweed Mitogens
Protein Kinase C - antagonists & inhibitors
Protein Kinase C - blood
protein-kinase C
Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis
SLE
Sulfonamides
title Inhibition of Protein-Kinase C in Peripheral Blood Mononuclear Cells of Patients with Systemic Lupus Erythematosus: Effect on Spontaneous Immunoglobulin Production
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T20%3A08%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inhibition%20of%20Protein-Kinase%20C%20in%20Peripheral%20Blood%20Mononuclear%20Cells%20of%20Patients%20with%20Systemic%20Lupus%20Erythematosus:%20Effect%20on%20Spontaneous%20Immunoglobulin%20Production&rft.jtitle=Autoimmunity%20(Chur,%20Switzerland)&rft.au=Chong,%20Penny&rft.date=1991&rft.volume=10&rft.issue=3&rft.spage=227&rft.epage=231&rft.pages=227-231&rft.issn=0891-6934&rft.eissn=1607-842X&rft_id=info:doi/10.3109/08916939109001893&rft_dat=%3Cproquest_pasca%3E72579543%3C/proquest_pasca%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72579543&rft_id=info:pmid/1756225&rfr_iscdi=true